Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BridgeBio Pharma, Inc. | Director | Common Stock | 980K | $30.7M | $31.30 | Jun 21, 2024 | By The Francis P. McCormick Rev Trust U/A DTD 1/27/2017 |
BridgeBio Pharma, Inc. | Director | Common Stock | 120K | $3.76M | $31.30 | Jun 21, 2024 | Direct |
BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Director |
BBIO | BridgeBio Pharma, Inc. | Dec 26, 2023 | 1 | -$4.21M | 4 | Dec 28, 2023 | Director |
BBIO | BridgeBio Pharma, Inc. | Feb 21, 2023 | 0 | $0 | 3 | Feb 28, 2023 | Director |
BBIO | BridgeBio Pharma, Inc. | Feb 21, 2023 | 1 | $0 | 4 | Feb 23, 2023 | Director |